Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Ainos reports preclinical data on low-dose oral interferon-alpha Veldona against COVID-19

June 28, 2022

Use of [89Zr]Prot-FH for neutrophil imaging during fungal infection

June 28, 2022

Brilacidin inhibits Omicron, Delta, Gamma and Alpha SARS-CoV-2 variants in vitro

June 27, 2022

Tokyo University of Science discloses LXR antagonists

June 27, 2022

Roche synthesizes new HBV HBsAg and HBeAg inhibitors

June 23, 2022

COR-803 reduces SARS-CoV-2 viral load in vivo after oral treatment

June 22, 2022

Roche describes new hepatitis B virus HBsAg and HBeAg inhibitors

June 22, 2022

Enanta Pharmaceuticals identifies new SARS-CoV-2 3C-like proteinase inhibitors

June 17, 2022

T cell-targeted vaccine for Coxiella burnetii infection shows promise in animal models

June 16, 2022

U.S. researchers divulge new compounds for SARS-CoV-2 infection

June 16, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...